Diabetes injection technique initiative launched
Nursing experts responsible for developing diabetes injection recommendations have teamed up with a remit to continue the dissemination of good practice.
The initiative ‘Injection Technique Matters (ITM) – Best Practice in Diabetes Care’ will be launched at this year’s Diabetes Professional Care conference, taking place at Olympia London on November 14 and 15.
The board includes Chair Debbie Hicks, a Nurse Consultant in Diabetes, Dr Debra Adams, Senior Infection Prevention and Control Advisor, and Jane Diggle, Specialist Practice Nurse, and Carole Gelder, CYP Diabetes Nurse Specialist.
They were previously part of the Forum for Injection Technique (FIT-UK), which was formed in 2009 to provide evidence-based best practice recommendations for both people with diabetes, their families, friends and healthcare professionals.
FIT-UK was launched in response to the lack of awareness around the impact of poor injection technique. The initiative achieved huge success in improving knowledge and skills relating to injection technique for both people with diabetes and healthcare professionals. FIT is global initiate and is still continuing with sponsorship from BD.
‘Excited and proud’
The team will be launching the new Injection Technique guideline and also the new Injection Technique Toolkit.
Debbie, who is a Nurse Consultant in Diabetes, said: “We are excited and proud to announce that B Braun, GlucoRx and Owen Mumford are now part of the new vision entitled Injection Technique Matters (ITM) – Best Practice in Diabetes Care.
“Come and see us at one of our many sessions at Diabetes Professional Care within the TREND-UK and Injection Technique Theatre and also receive your personal Injection Technique Matters Toolkit and copy of the guideline. The guideline will also be available from our sponsors plus as a download from the TREND-UK website from November 14.”
This initiative is recognised and endorsed by Diabetes UK, Lilly, Novo Nordisk, Sanofi and AstraZeneca.
Injection Technique Matters is managed under the well-recognised and respected TREND-UK organisation. It has been made possible thanks to sponsorship.
Commenting on the new sponsorship, sponsors B. Braun said: “B. Braun is one of the world’s leading providers and manufacturers of healthcare solutions today, established for over 175 years. Our focus in Diabetes Care is to offer high quality products, innovative value-added services and educational literature for both patients and healthcare professionals.
“B. Braun’s corporate Vision is to ‘Protect and improve the health of people around the world’ and we are very excited to be directly supporting the Injection Technique Matters Initiative.
“ITM aims to educate Nurses and their patients on best practice Injection Technique and by supporting an initiative like this B. Braun hope to be able to make a difference to people with diabetes. We truly believe ITM has the power to increase awareness, improve understanding and empower patients to make the small changes that can make a big difference.”
A statement from fellow sponsors GlucoRx said: “GlucoRx Ltd is very pleased to sponsor and unconditionally support this first edition of the ‘Injection Technique Matters – Best Practice in Diabetes Care’.
“Achieving the best injection technique possible enhances the lives of the many people living with diabetes having to medicate with injectables, helping them to obtain the best possible (and individualised) outcomes and to minimise the risks involved. It is vitally important for them to be taught correctly from the outset and to have access to the most relevant information.
“The contents of this document will allow healthcare professionals to access the latest research and to promote the importance of adhering to the latest recommendations on injection technique. Promoting best practice plays a core role in GlucoRx’s day to day activities and helping to disseminate these practical guidelines could not be more in line with our company’s ethos.”
Sponsors Owen Mumford added: “Owen Mumford is committed to supporting patients using injectable therapies, and the healthcare professionals who care for them. For over 65 years Owen Mumford has delivered innovative medical device solutions designed to help medical professionals improve the delivery and management of treatments for a variety of therapy areas and conditions, and which in turn help patients to better self-manage these conditions.
“We recognise the role that initiatives such as Injection Technique Matters have in facilitating optimum injection techniques, promoting good routines and enhancing the care of patients with diabetes. It is important that patients receive the benefits of treatment, avoid long-term complications and achieve favourable clinical outcomes.
“Our aim is to improve lives and reduce healthcare costs, and Owen Mumford appreciates that the added-value of best practice guidelines, ongoing education and support programmes can all contribute to achieving positive health outcomes. We are delighted to support the Injection Technique Matters initiative.”